sulfasalazine has been researched along with MS (Multiple Sclerosis) in 7 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulfasalazine is an anti-inflammatory and immune-modulating drug that is used in rheumatology and inflammatory bowel disease." | 1.42 | Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination. ( Chang, KY; Cho, SC; Ha, YW; Kim, S; Lee, DW; Lee, YI; Na, JE; Park, HC; Park, SC; Rhyu, IJ, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, S | 1 |
| Lee, YI | 1 |
| Chang, KY | 1 |
| Lee, DW | 1 |
| Cho, SC | 1 |
| Ha, YW | 1 |
| Na, JE | 1 |
| Rhyu, IJ | 1 |
| Park, SC | 1 |
| Park, HC | 1 |
| Noseworthy, JH | 1 |
| O'Brien, P | 1 |
| Erickson, BJ | 1 |
| Lee, D | 1 |
| Sneve, D | 1 |
| Ebers, GC | 1 |
| Rice, GP | 1 |
| Auty, A | 1 |
| Hader, WJ | 1 |
| Kirk, A | 1 |
| Duquette, P | 1 |
| Carter, J | 1 |
| Francis, G | 1 |
| Metz, L | 1 |
| Shuster, E | 1 |
| Rudge, P | 1 |
| Paty, DW | 1 |
| Uitdehaag, BM | 1 |
| Polman, CH | 1 |
| de Groot, CJ | 1 |
| Huitinga, I | 1 |
| Dijkstra, CD | 1 |
| Gold, R | 1 |
| Kappos, L | 1 |
| Becker, T | 1 |
| Prosiegel, M | 1 |
| Neu, I | 1 |
| Ruhenstroth-Bauer, G | 1 |
| Hoffmann, G | 1 |
| Vogl, S | 1 |
| Mehlber, L | 1 |
| Wildfeuer, A | 1 |
1 trial available for sulfasalazine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
The Mayo Clinic-Canadian Cooperative trial of sulfasalazine in active multiple sclerosis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Brain; Canada; Disabled Persons; Disease Progression | 1998 |
6 other studies available for sulfasalazine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination.
Topics: Animals; Animals, Genetically Modified; Anti-Inflammatory Agents, Non-Steroidal; Axons; Disease Mode | 2015 |
Are clinical trials of therapeutic agents for MS long enough?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Humans; Interferon-beta; Multiple | 1999 |
The Mayo Clinic-Canadian cooperative trial of sulfasalazine in active multiple sclerosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Canada; Clinical Trials as Topic; Humans; Minnesota; Multip | 1999 |
Failure of sulfasalazine to influence experimental autoimmune encephalomyelitis.
Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Humans; Multiple Sclerosis; Neurologic Examina | 1991 |
Development of multiple sclerosis in patient on long-term sulfasalazine.
Topics: Adult; Colitis, Ulcerative; Drug Administration Schedule; Humans; Male; Multiple Sclerosis; Sulfasal | 1990 |
Suppression of experimental autoimmune encephalomyelitis by sulfasalazine.
Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Female; Guinea Pigs; Multiple Sclerosis; Sulfa | 1989 |